Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neurocrine B
AddedMar 19, 2024
UpdatedJun 28, 2026
Neurocrine B

Neurocrine B

Public

San Diego-based medical organization developing therapies for brain-related diseases.

HQ
San Diego, CA, US
Founded
1992
Overview
Compare
Fundraising
Employees
Website

Neurocrine Biosciences, Inc., founded in San Diego, California, is dedicated to discovering, developing, and marketing pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's mission is to alleviate patient suffering through innovative treatments. Their product portfolio includes INGREZZA and DYSVAL for tardive dyskinesia, and ONGENTYS as an adjunctive therapy for Parkinson's disease. Neurocrine also focuses on treatments for endometriosis and uterine fibroids, with ongoing clinical programs in various therapeutic areas.

Notable figures associated with Neurocrine include its leadership team and key investors who have supported its growth. The company has achieved significant milestones, such as the successful commercialization of its flagship products, which have had a substantial impact on patient care. Neurocrine's contributions to medical science have positioned it as a leader in the biopharmaceutical industry, particularly in the realm of brain-related diseases.

Neurocrine B - Similar Companies

Crinetics Pharmaceuticals logo

Crinetics Pharmaceuticals

crinetics.com

Neurolixis logo

Neurolixis

neurolixis.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Synchroneuron logo

Synchroneuron

Acadia Pharmaceuticals logo

Acadia Pharmaceuticals

acadia-pharm.com

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

Neurovia logo

Neurovia

NeuroBionics logo

NeuroBionics

Neurogene logo

Neurogene

neurogene.com

Acorda Therapeutics logo

Acorda Therapeutics

acorda.com

NeuroPro Therapeutics logo

NeuroPro Therapeutics

Harmony Biosciences logo

Harmony Biosciences

Intellect Neurosciences logo

Intellect Neurosciences

Neurolink logo

Neurolink

Neurocrine B - Quick Facts

Who are Neurocrine B's competitors?

Companies similar to Neurocrine B include Crinetics Pharmaceuticals, Neurolixis, NeuroTherapeutics Pharma and Synchroneuron.

When was Neurocrine B founded?

Neurocrine B was founded in 1992.

Where is Neurocrine B's headquarters located?

Neurocrine B's headquarters is located in San Diego, CA, US.

When was Neurocrine B's last funding round?

Neurocrine B's most recent funding round was for $250M (USD) in February 2015.

How much has Neurocrine B raised to-date?

As of Feb 19, 2015, Neurocrine B has raised a total of $260M (USD).

How many employees does Neurocrine B have?

Neurocrine B has 1,200 employees as of Feb 6, 2024.

Neurocrine B - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapeutics
Tags
  • Biotech
  • Healthcare
  • Healthtech
Unique IDs
  • ein: 330525145
  • secCik: 0000914475
  • ticker: NBIX
NAICS
  • 456000Health and Personal Care Retailers
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 450000Retail Trade
  • 541000Professional, Scientific, and Technical Services
  • 456100Health and Personal Care Retailers
  • 541700Scientific Research and Development Services
  • 456110Pharmacies and Drug Retailers
  • 541510Computer Systems Design and Related Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541511Custom Computer Programming Services
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 7300Business Services
  • 2830Drugs
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 23 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 5900Miscellaneous Retail
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5910Drug Stores And Proprietary Stores
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research